Product overview
A synthetic peptide analog studied in laboratory models of growth-hormone-releasing-hormone pathways. Supplied for controlled in-vitro investigation of pituitary signaling.

From
$74.99
A synthetic peptide analog studied in laboratory models of growth-hormone-releasing-hormone pathways. Supplied for controlled in-vitro investigation of pituitary signaling.
Select vial size
Quantity
Research background
Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH). Research has focused on its ability to stimulate endogenous growth hormone release and influence downstream IGF-1 signaling.
Tesamorelin has been clinically studied for specific medical indications, while research continues into its broader metabolic and physiological effects. It should not be represented as a general-purpose fat-loss or bodybuilding compound.
Research disclaimer
All products are supplied strictly for in-vitro laboratory research, analytical research, or other legitimate scientific research purposes where applicable. Products are not intended for human or veterinary consumption, diagnosis, treatment, prevention, or mitigation of disease. Information presented on this website describes areas investigated in scientific literature and does not constitute medical advice or a claim that any product is safe or effective for a particular use. Research findings may include in-vitro, animal, observational, or limited human studies and should not be interpreted as equivalent to established clinical evidence. Many compounds in the research-peptide field lack sufficient human safety and efficacy data.
A synthetic peptide analog studied in laboratory models of growth-hormone-releasing-hormone pathways. Supplied for controlled in-vitro investigation of pituitary signaling.
Information is presented for laboratory and analytical context only. Researchers should consult primary scientific literature and applicable institutional protocols.
Quantity: 10mg. Appearance, formula, molecular weight, and storage conditions will be published only when verified product documentation is available.
Lot number, test date, identity, purity, testing laboratory, and COA fields remain intentionally unpopulated until genuine Valora batch documentation is connected.